Imatinib mesylate in the management of chemotherapy-induced pulmonary toxicity: a double-edged sword

Authors

  • Ahmet Emre Eskazan Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey

DOI:

https://doi.org/10.1080/0284186X.2018.1502469

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2019-01-02

How to Cite

Emre Eskazan, A. (2019). Imatinib mesylate in the management of chemotherapy-induced pulmonary toxicity: a double-edged sword. Acta Oncologica, 58(1), 123–124. https://doi.org/10.1080/0284186X.2018.1502469

Issue

Vol. 58 No. 1 (2019): Acta Oncologica

Section

Articles